Rader DJ. Chapter 407: Disorders of Lipoprotein Metabolism. In: Loscalzo J, Kasper DL, Longo DL, Fauci AS, Hauser SL, Jameson JL, ed. Harrison’s Principles of Internal Medicine. 21st ed. McGraw Hill; 2022:3135-3150.

Brown MS, Goldstein JL. A Receptor-Mediated Pathway for Cholesterol Homeostasis. Science. 1986;232(4746):34–47. https://doi.org/10.1126/science3513311.

Article  CAS  PubMed  Google Scholar 

Motazacker MM, Pirruccello J, Huijgen R, et al. Advances in genetics show the need for extending screening strategies for autosomal dominant hypercholesterolaemia. Eur Heart J. 2012;33:1360–6. https://doi.org/10.1093/eurheartj/ehs010.

Article  CAS  PubMed  Google Scholar 

Ison HE, Clarke SL, Knowles JW. Familial Hypercholesterolemia. 2014 Jan 2 [Updated 2022 Jul 7]. In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK174884/. Accessed 20 Feb 2024

Wiegman A, Gidding SS, Watts GF, et al. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. Eur Heart J. 2015;36:2425–37. https://doi.org/10.1093/eurheartj/ehv157.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chora JR, Medeiros AM, Alves AC, Bourbon M. Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application o fACME guidelines and implications for familial hypercholesterolemia diagnosis. Genet Med. 2018;20(6):591–8. https://doi.org/10.1038/gim.2017.151.

Article  CAS  PubMed  Google Scholar 

Leigh S. The LDLR gene homepage. LOVD3 Leiden Open Variation Database. Updated August 10, 2023. Accessed October 11, 2023. https://databases.lovd.nl/shared/genes/LDLR.

Benn M, Watts GF, Tybjaerg-Hansen A, Nordestgaard BG. Mutations causative of familial hypercholesterolaemia: screening of 98,098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217. Eur Heart J. 2016;37:1384–94. https://doi.org/10.1093/eurheartj/ehw028.

Article  CAS  PubMed  Google Scholar 

Strum AC, Knowles JW, Gidding SS, et al. Clinical Genetic Testing for Familial Hypercholesterolemia. JACC. 2018;72(6):662–80. https://doi.org/10.1016/j.jacc.2018.05.044.

Article  Google Scholar 

Hu P, Dharmayat KI, Stevens CA, et al. Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease. Circulation. 2020;131:1742–59. https://doi.org/10.1161/circulationaha.119.044795.

Article  Google Scholar 

Akioyamen LE, Genest J, Shan SD, et al. Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis. BMJ Open. 2017;7:e016461. https://doi.org/10.1136/bmjopen-2017-016461.

Article  PubMed  PubMed Central  Google Scholar 

Nordestgaard BG, Chapman MJ, Humphries SE, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease. Eur Heart J. 2013;34:3478–90. https://doi.org/10.1093/eurheartj/eht273.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khera AV, Won HH, Peloso GM, et al. Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia. J Am Coll Cardiol. 2016;67(22):2578–89. https://doi.org/10.1016/j.jacc.2016.03.520.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128 Suppl 5(Suppl 5):S213-S256. https://doi.org/10.1542/peds.2009-2107C

Wald DS, Bestwick JP, Morris JK, et al. Child-Parent Familial Hypercholesterolemia Screening in Primary Care. N Engl J Med. 2016;375(17):1628–37. https://doi.org/10.1056/NEJMoa1602777.

Article  CAS  PubMed  Google Scholar 

Betteridge DJ, Broome K, Durrington PN, et al. Risk of fatal coronary heart disease in familial hypercholesterolaemia. BMJ. 1991;303(6807):893–6. https://doi.org/10.1136/bmj.303.6807.893.

Article  Google Scholar 

Austin MA, Hutter CM, Zimmern RL, Humphries SE. Genetic Causes of Monogenic Heterozygous Familial Hypercholesterolemia: A HuGE Prevalence Review. Am J Epidemiol. 2004;160(5):407–20. https://doi.org/10.1093/aje/kwh236.

Article  PubMed  Google Scholar 

Gidding SS, Champagne MA, de Ferranti SD, et al. The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association. Circulation. 2015;132:2167–92. https://doi.org/10.1161/CIR.0000000000000297.

Article  PubMed  Google Scholar 

Daniels SR, Gidding SS, de Ferranti SD. Pediatric aspects of Familial Hypercholesterolemias: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011;5:S30–7. https://doi.org/10.1016/j.jacl.2011.03.453.

Article  PubMed  Google Scholar 

Langstead A, Kamstrup PR, Benn M, Tybjaerg-Hansen A, Nordestgaard BG. High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study. Lancet Diabetes Endocrinol. 2016;4:577–87. https://doi.org/10.1016/S2213-8587(16)30042-0.

Article  CAS  Google Scholar 

Huijgen R, Hutten BA, Kindt I, Vissers MN, Kastelein JJ. Discriminative Ability of LDL-Cholesterol to Identify Patients With Familial Hypercholesterolemia. Circ Cardiovasc Genet. 2012;5:354–9. https://doi.org/10.1161/CIRCGENETICS.111.962456.

Article  CAS  PubMed  Google Scholar 

Starr B, Hadfield SG, Hutten BA, et al. Development of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing. CCLM. 2008;46(6):791–803. https://doi.org/10.1515/CCLM.2008.135.

Article  CAS  PubMed  Google Scholar 

Banderali G, Capra ME, Biasucci G, Stracquadaino R, Viggiano C, Pederiva C. Detecting Familial hypercholesterolemia in children and adolescents: potential and challenges. Ital J Pediatr. 2022;48:115. https://doi.org/10.1186/s13052-022-01257-y.

Article  PubMed  PubMed Central  Google Scholar 

Wald DS, Bestwick JP, Wald NJ. Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis. BMJ. 2007;335(7620):599. https://doi.org/10.1136/bmj.39300.616076.55.

Article  PubMed  PubMed Central  Google Scholar 

Vinson A, Guerra L, Hamilton L, Wilson DP. Reverse Cascade Screening for Familial Hypercholesterolemia. J Pediatr Nurs. 2019;44:50–5. https://doi.org/10.1016/j.pedn.2018.09.011.

Article  PubMed  Google Scholar 

Watts GF, Gidding SS, Hegele RA, et al. International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia. Nat Rev Cardiol. 2023;20:845–69. https://doi.org/10.1038/s41569-023-00892-0.

Article  PubMed  Google Scholar 

Jacobson TA, Maki KC, Orringer CE, et al. National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2. J of Clin Lipidol. 2015;9:S1–122. https://doi.org/10.1016/j.jacl.2015.09.002.

Article  Google Scholar 

McGowan MP, Cuchel M. Universal paediatric screening for familial hypercholesterolaemia. Lancet. 2024;403(10421):6–8. https://doi.org/10.1016/S0140-6736(23)02182-7.

Article  PubMed  Google Scholar 

de Ferranti SD, Rodday AM, Parsons SK, et al. Cholesterol Screening and Treatment Practices and Preferences: A Survey of United States Pediatricians. J Pediatr. 2017;185:99–105. https://doi.org/10.1016/j.jpeds.2016.12.078.

Article  PubMed  Google Scholar 

Cuchel M, Raal FJ, Hegele RA, et al. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance. Eur Heart J. 2023;44:2277–91. https://doi.org/10.1093/eurheartj/ehad197.

Article  PubMed  PubMed Central  Google Scholar 

Cortez AB, Salvador M, Li Q, Briscoe A. Universal lipid screening in adolescents to identify familial hypercholesterolemia in a large healthcare system. J Clin Lipidol. 2023;18(2):E166–75. https://doi.org/10.1016/j.jacl.2023.11.016.

Article  PubMed  Google Scholar 

Jackson CL, Huschka T, Borah B, et al. Cost-effectiveness of cascade genetic testing for familial hypercholesterolemia in the United States. AJPC. 2021;8:100245. https://doi.org/10.1016/j.aipc.2021.100245.

Article